However, the difference in all-cause mortality between the patients initiating cART at CD4 cell counts <500 and those at CD4 cell counts ≧500 cells/mm 3 did not reach statistical significance (HR, 3.37; 95% CI, 0.46–24.78) ( Fig 3B ).
← all excerpts
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up.
1
—
—